Results 41 to 50 of about 469,352 (221)

Uptake of Pneumococcal Vaccines Among U.S. Adults After 2022 Update to Recommendations

AJPM Focus
Introduction: Updated recommendations for adult pneumococcal vaccination in the U.S. (publication date: January 27, 2022) incorporated 2 new vaccines (15- and 20-valent pneumococcal conjugate vaccines), removed 13-valent pneumococcal conjugate vaccine ...
Ahuva Averin, MPP, Jeffrey Vietri, PhD, Adriano Arguedas Mohs, MD, Sarah J. Willis, PhD, MPH, Alexander Lonshteyn, PhD, Derek Weycker, PhD   +5 more
doaj   +1 more source

Genetic diversity of Streptococcus pneumoniae causing meningitis and sepsis in Singapore during the first year of PCV7 implementation

Emerging Microbes and Infections, 2014
Streptococcus pneumoniae is a major cause of sepsis, meningitis and respiratory disease worldwide. Pneumococcal conjugate vaccines (PCVs) have now been implemented in many countries worldwide, including Singapore.
Elita Jauneikaite, Johanna Mary Carnon Jefferies, Nicholas William Vere Churton, Raymond Tzer Pin Lin, Martin Lloyd Hibberd, Stuart Charles Clarke   +5 more
doaj   +1 more source

A brief history of and future prospects for pneumococcal vaccination in Malaysia

Pneumonia, 2023
Pneumococcal pneumonia remains a significant global public health issue. Malaysia has recently added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme.
Alex J. J. Lister, Evelin Dombay, David W. Cleary, Lokman H. Sulaiman, Stuart C. Clarke   +4 more
doaj   +1 more source

Pneumococcal carriage in sub-Saharan Africa--a systematic review. [PDF]

, 2014
BACKGROUND: Pneumococcal epidemiology varies geographically and few data are available from the African continent. We assess pneumococcal carriage from studies conducted in sub-Saharan Africa (sSA) before and after the pneumococcal conjugate vaccine (PCV)
Bottomley, Christian, Andrew Hall, Richard A. Adegbola (20657), Hall, Andrew, Hall Andrew, Effua Usuf (334925), Effua Usuf, Christian Bottomley, Adegbola Richard A., Bottomley Christian, Adegbola, Richard A, Usuf, Effua, Usuf Effua, Andrew Hall (223292), Richard A Adegbola, Christian Bottomley (144483)   +15 more
core   +1 more source

EXPERIENCE OF APPLICATION AND SAFETY ASSESSMENT OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN UNDER-5 CHILDREN

Педиатрическая фармакология, 2014
Compulsory use of the 7-valent pneumococcal conjugate vaccine in the framework of national pediatric immunization schedules of the developed countries resulted in significant decrease in the prevalence of the pneumococcal infections induced by the ...
M. V. Fedoseenko, D. A. Novikova, N. E. Tkachenko, M. I. Broeva, T. A. Grechukha, A. G. Gaivoronskaya, V. V. Chernikov   +6 more
doaj   +1 more source

ERA OF CONJUGATE VACCINES: INTERNATIONAL EXPERIENCE OF SUCCESSFUL APPLICATION

Педиатрическая фармакология, 2008
The article highlights comparative characteristics of the polysaccharide and conjugate vaccines against pneumococcal infection, meningococcosis and haemophilus influenza. The author stresses the advantage of the conjugate vaccines.
M.V. Fedoseenko, M.G. Galitskaya, L.S. Namazova   +2 more
doaj   +2 more sources

Clinical and bacteriological characteristics of invasive pneumococcal disease after pneumococcal 10-valent conjugate vaccine implementation in Salvador, Brazil

Brazilian Journal of Infectious Diseases, 2016
Invasive pneumococcal disease is a relevant public health problem in Brazil, especially among children and the elderly. In July/2010 a 10-valent pneumococcal conjugate vaccine was introduced to the immunization schedule of Brazilian children under two ...
Carolina Regis Leite, Jailton Azevedo, Vivian Santos Galvão, Otávio Moreno-Carvalho, Joice Neves Reis, Cristiana Nascimento-Carvalho   +5 more
doaj   +1 more source

Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial [PDF]

, 2014
BACKGROUND: In a previous UK multi-center randomized study 278 children received three doses of 7-valent (PCV-7) or 13-valent (PCV-13) pneumococcal conjugate vaccine at 2, 4 and 12 months of age.
Trück, J, Yu, Ly-Mee, Finn, Adam, Ly-Mee Yu (44961), Pollard, Andrew J, Pollard Andrew J., Trück, Johannes; https://orcid.org/, Faust, Saul N, Johannes Trück, Merryn Voysey, Paul T. Heath (533551), Yu Ly-Mee, Voysey, M, Saul N. Faust (415924), Tatangeli, F, Andrew J Pollard, Voysey Merryn, Heath Paul T., Tatangeli, Florencia, Adam Finn (23223), Florencia Tatangeli (533550), Faust, S.N., Snape, MD, Pollard, AJ, Pollard, Andrew, Heath, PT, Adam Finn, Snape, Matthew, Merryn Voysey (255058), Faust Saul N., Andrew J. Pollard (44971), Snape Matthew D., Heath, Paul T, Voysey, Merryn, Yu, LM, Paul T Heath, Finn Adam, Tatangeli Florencia, Matthew D. Snape (533549), Faust, SN, Matthew D Snape, Finn, A, Snape, Matthew D, Florencia Tatangeli, Saul N Faust, Pollard, Andrew J., Ly-Mee Yu, Johannes Trück (533548), Truck, Johannes, Trück Johannes, Heath, Paul   +50 more
core   +1 more source

Artificial Intelligence‐Guided Phenotypic Drug Repurposing Against Streptococcus pneumoniae

Advanced Science, EarlyView.
Integrated artificial intelligence (AI) ensembles identify highly potent repurposed drugs against Streptococcus pneumoniae. Prospective virtual screening of 6747 drugs uncovers nine active candidates, including thiostrepton. This drug exhibits low picomolar potency and bypasses established resistance in multidrug‐resistant strains, demonstrating an ...
Joshua S. Fitch, Muhammad D. Ariadi, Min Jung Kwun, Leonie Howells, Saiveth Hernandez‐Hernandez, Nicholas J. Croucher, Pedro J. Ballester   +6 more
wiley   +1 more source

Continued control of pneumococcal disease in the UK - the impact of vaccination

, 2011
Streptococcus pneumoniae, also known as the pneumococcus, is an important cause of morbidity and mortality in the developed and developing world. Pneumococcal conjugate vaccines were first introduced for routine use in the USA in 2000, although the seven-
Gladstone, R.A., Jefferies, J.M., Gladstone, R.A, S. N. Faust, Faust, S.N, Faust, S.N ., R. A. Gladstone, Clarke, S.C., J. M. Jefferies, Jefferies, J.M, Clarke, S.C, S. C. Clarke   +11 more
core   +1 more source